Are Group Psychotherapeutic Treatments Effective for Patients with Schizophrenia? A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Different psychotherapeutic treatments for schizophrenia are delivered in groups. However, little is known about the effectiveness of these group therapies for people with schizophrenia across different treatments with varying therapeutic orientations. This review aimed to (1) estimate the effect of different group psychotherapeutic treatments for schizophrenia and (2) explore whether any overall ‘group effect' is moderated by treatment intensity, diagnostic homogeneity and therapeutic orientation. Methods: A systematic search of randomised controlled trials exploring the effectiveness of group psychotherapeutic treatments for people with schizophrenia was conducted. Random-effect meta-analyses on endpoint symptom scores compared group psychotherapeutic treatments with treatment as usual and active sham groups. Findings on social functioning were described narratively, and meta-regression analyses on group characteristics were carried out. Results: Thirty-four eligible trials were included. A weak-to-moderate significant between-group difference in favour of group psychotherapeutic treatments was found for negative symptom scores (standard mean difference = -0.37, 95% confidence interval -0.60, -0.14; p < 0.01, I 2 = 59.8%) only when compared to treatment as usual and not to active sham groups. Improved social functioning was reported as a treatment outcome in the majority of studies compared to treatment as usual. The ‘group effect' on negative symptoms was positively related to ‘treatment intensity' (β = 0.32, standard error = 0.121; p < 0.05). Conclusion: Group psychotherapeutic treatments can improve negative symptoms and social functioning deficits in the treatment of schizophrenia. The effect occurs across different treatments and appears to be non-specific. Future research should identify the underlying mechanisms for the positive effect of participating in groups and explore how they can be maximised to increase the therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
Wykes, T., Huddy, V., Cellard, C., McGurk, S. R., & Czobor, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10060855 · Cited by 1,693
Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm114 · Cited by 1,029 · cited 1×
“Whilst Wykes and colleagues [67] found no difference in the two treatment modalities, the validity of this comparison is limited by the fact that only seven group CBT studies were compared to 26 studies on individual CBT.”
ResultJauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.116285 · Cited by 517 · cited 2×
“Low-quality studies were excluded in planned sensitivity analyses rather than being rated on a quality scale and controlled for statistically [64].”
BackgroundResultThe Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp130 · Cited by 499
Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research
Kurtz, M. M., & Richardson, C. L. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr036 · Cited by 446
Psychosocial Treatments in Schizophrenia: A Review of the Past 20 Years
HUXLEY, N. A., RENDALL, M., & SEDERER, L. (2000) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200004000-00001 · Cited by 152
Hunter, R., & Barry, S. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.015 · Cited by 138
Granholm, E., Holden, J., Link, P. C., McQuaid, J. R., & Jeste, D. V. (2013) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.014 · Cited by 135 · cited 1×
“In total, 13 data sets compared a group psychotherapeutic treatment to an active sham group [37, 39, 41-51], and 19 data sets compared a group psychotherapeutic treatment to treatment-as-usual [7, 12, 13, 34, 40, 41, 52-63].”
BackgroundThe Mindfulness-Based Psychoeducation Program for Chinese Patients With Schizophrenia
Chien, W. T., & Lee, I. Y. M. (2013) · Psychiatric Services · doi:10.1176/appi.ps.002092012 · Cited by 87
Zimmer, M., Duncan, A. V., Laitano, D., Ferreira, E. E., & Belmonte-de-Abreu, P. (2007) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462006005000030 · Cited by 34
Variation in results from randomized, controlled trials: stochastic or systematic?
Jane-wit, D., Horwitz, R. I., & Concato, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.02.010 · Cited by 33 · cited 1×
“However, as noted by Jane-Wit and colleagues [65], an important factor contributing to different results between randomised controlled trials, is the difference in patient characteristics.”
Background
Cited by
Mann, F., Bone, J. K., Lloyd-Evans, B., Frerichs, J., Pinfold, V., Ma, R., Wang, J., & Johnson, S. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-017-1392-y · Cited by 346
Solmi, M., Croatto, G., Piva, G., Rosson, S., Fusar-Poli, P., Rubio, J. M., Carvalho, A. F., Vieta, E., Arango, C., DeTore, N. R., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01727-z · Cited by 147
“0 % Orfanos 2015[75] Group psychotherapy Mixed 0 2 1 0 0 0 3 7 10 L 6 / 32 18.”
Garg, S., Sinha, V. K., Tikka, S. K., Mishra, P., & Goyal, N. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.023 · Cited by 95
Schizophrenia: An exploration of an acceptance, mindfulness, and compassion-based group intervention
Martins, M. J., Castilho, P., Santos, V., & Gumley, A. (2017) · Australian Psychologist · doi:10.1111/ap.12210 · Cited by 13
Metadata
- Authors
- Orfanos, S., Banks, C., & Priebe, S.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 84
- Issue
- 4
- Pages
- 241-249
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W1674156117
- Cited by
- 51
- References
- 12
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.